MAXCYTE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 291 GBX | -1.36% |
|
-7.62% | -17.45% |
| Apr. 02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
| Apr. 02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MarketScreener Strategies
